Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 3/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25305253 | 0.88 | HTR2A (0.47) | PTPN1HTR2ASMN1; SMN2NPSR1MAPT | |
| SCHEMBL25842179 | 0.80 | SOS2 (0.49) | HTR2ACYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL25842226 | 0.77 | KDM4E (0.42) | PTPN1SMN1; SMN2NPSR1MAPTHTT | |
| SCHEMBL25842370 | 0.76 | TNF (0.42) | HTR2ANPSR1MAPTHPGDALDH1A1 | |
| SCHEMBL9965006 | 0.76 | HTR2A (0.41) | HTR2ASMN1; SMN2NPSR1MAPT | |
| SCHEMBL25842164 | 0.72 | CYP19A1 (0.38) | CYP19A1HTR2ASMN1; SMN2NPSR1HTT | |
| SCHEMBL26202274 | 0.72 | MTNR1A (0.46) | SMN1; SMN2NPSR1MAPTHPGDALDH1A1 | |
| SCHEMBL20553126 | 0.69 | TNF (0.44) | HTR2ANPSR1MAPTHPGDALDH1A1 | |
| SCHEMBL26203869 | 0.69 | GPR84 (0.41) | CYP19A1HTR2A | |
| SCHEMBL10344946 | 0.67 | SMN1; SMN2 (0.42) | HTR2ASMN1; SMN2NPSR1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219888-A1 | PRENYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | MAGICMED INDUSTRIES INC. (CA) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219888-A1 | PRENYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | AANAT, ACAT2, PCYT1A | CYP19A1 445/4885PTPN1 4404/4885HTR2A 1566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.